Unusual Antibodies In Cows Suggest New Ways To Make Therapies For PeopleRedOrbitHumans have been raising cows for their meat, hides and milk for millennia. Now it appears that the cow immune system also has something to offer. A new study led by scient…
Science Codex |
Unusual antibodies in cows suggest new ways to make therapies for people
Phys.Org The image, which appears on the cover of the June 6, 2013, issue of the journal Cell, shows the stalk and disulfide bonded knob of the cow antibody BLV1H12 (light green, right) overlaid onto the oil painting “Red Calf Portrait” by San Diego artist … Cow antibodies may treat human diseasesU-T San Diego Fabrus Scientists’ Work Published in Journal CellMarketWatch (press release) |
BioLineRx Enrolls First Patient in Phase 2 Clinical Trial for BL-8040, for …PharmaLive (press release) (subscription)Pre-clinical studies show that BL-8040 is efficient, both alone and in combination with the anti-cancer drug Rituximab, in reducing b…
|
Unusual antibodies in cows suggest new ways to make therapies for people
Science Codex LA JOLLA, CA – June 6, 2013 – Humans have been raising cows for their meat, hides and milk for millennia. Now it appears that the cow immune system also has something to offer. A new study led by scientists from The Scripps Research Institute (TSRI) … |
|
Cow antibodies may treat human diseases
U-T San Diego LA JOLLA — Antibodies from cows may provide a new source of drugs for human diseases such as AIDS, according to a study led by Scripps Research Institute scientists. Bovines produce unusual antibodies that are very efficient in grabbing onto molecular … Unusual Antibodies in Cows Suggest New Ways to Make Therapies for PeopleNewswise (press release) Fabrus Scientists’ Work Published in Journal CellMarketWatch (press release) |
|
Fabrus Scientists’ Work Published in Journal Cell
MarketWatch (press release) LA JOLLA, Calif., June 6, 2013 /PRNewswire via COMTEX/ — Fabrus Inc., a company developing a next-generation antibody discovery platform that expands the therapeutic applications of antibodies, today announced the publication of data in the journal … |
|
Cowen Questions Sales Growth Of Biogen Idec’s MS Drug Tecfidera
Seeking Alpha AVONEX® (interferon beta-1a), TYSABRI® (natalizumab) and RITUXAN® (rituximab) are Biogen’s other primary drugs in the MS indication. These three brought in the vast majority of the company’s $1.4 B in quarterly revenues ($736 million, $275 million and … |
|
Monoclonal Antibodies Market Dealmaking in Biopharma Industry Analyzed in …
Watch List News (press release) The Monoclonal Antibodies Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the monoclonal antibodies partnering deals and agreements entered into by the world’s leading healthcare … |
|
Monoclonal Antibodies Market Dealmaking in Biopharma Industry Analyzed in …
PR Web (press release) The Monoclonal Antibodies Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the monoclonal antibodies partnering deals and agreements entered into by the world’s leading healthcare … |
Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 – Market …PR Newswire UK (press release)The currently marketed monoclonal antibodies are clinically and commercially highly successful products in the rheumatoid arthritis market, constitut…